These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 32286266

  • 21. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y, Li H, Yi D, Sun Y, Bai Y, Zhong S, Song Y, Zhao G, Chen Y.
    Mol Pharm; 2018 Nov 05; 15(11):4912-4925. PubMed ID: 30336060
    [Abstract] [Full Text] [Related]

  • 22. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q, Guan Y, Li Z, Wang Y, Liu Y, Cui R, Wang Y.
    J Exp Clin Cancer Res; 2019 Aug 16; 38(1):358. PubMed ID: 31419987
    [Abstract] [Full Text] [Related]

  • 23. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J, Zhang XY, Sun DK, Tian LQ, Xu P.
    Eur Rev Med Pharmacol Sci; 2019 Apr 16; 23(8):3447-3454. PubMed ID: 31081099
    [Abstract] [Full Text] [Related]

  • 24. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
    Liu J, Jiang J, Hui X, Wang W, Fang D, Ding L.
    Cell Physiol Biochem; 2018 Apr 16; 48(5):2074-2083. PubMed ID: 30099442
    [Abstract] [Full Text] [Related]

  • 25. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y, He Y, Lv S, Hou X, Li L, Song J.
    J Drug Target; 2019 Jan 16; 27(1):60-66. PubMed ID: 29768063
    [Abstract] [Full Text] [Related]

  • 26. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
    Chen Q, Weng HY, Tang XP, Lin Y, Yuan Y, Li Q, Tang Z, Wu HB, Yang S, Li Y, Zhao XL, Fu WJ, Niu Q, Feng H, Zhang X, Wang Y, Bian XW, Yao XH.
    J Pathol; 2019 Feb 16; 247(2):266-278. PubMed ID: 30357833
    [Abstract] [Full Text] [Related]

  • 27. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
    Ni H, Ji D, Huang Z, Li J.
    Arch Biochem Biophys; 2020 Nov 30; 695():108628. PubMed ID: 33049294
    [Abstract] [Full Text] [Related]

  • 28. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN, Tian R, Zhang M, Gui ZH, Wu J, Ding M, Zhou XF, He J.
    Oncotarget; 2016 Nov 29; 7(48):78813-78826. PubMed ID: 27705931
    [Abstract] [Full Text] [Related]

  • 29. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.
    Aguila B, Morris AB, Spina R, Bar E, Schraner J, Vinkler R, Sohn JW, Welford SM.
    Cancer Lett; 2019 Oct 10; 462():33-42. PubMed ID: 31377205
    [Abstract] [Full Text] [Related]

  • 30. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A, Kato T, Kinjo S, Enomoto A, Toda H, Shimato S, Ohka F, Motomura K, Kondo Y, Miyata T, Takahashi M, Wakabayashi T.
    Oncogene; 2012 May 31; 31(22):2715-24. PubMed ID: 22020337
    [Abstract] [Full Text] [Related]

  • 31. Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma.
    Chen HY, Lin LT, Wang ML, Lee SH, Tsai ML, Tsai CC, Liu WH, Chen TC, Yang YP, Lee YY, Chang YL, Huang PI, Chen YW, Lo WL, Chiou SH, Chen MT.
    Oncotarget; 2016 Jul 05; 7(27):42485-42501. PubMed ID: 27285760
    [Abstract] [Full Text] [Related]

  • 32. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC, Huang XH.
    Cancer Lett; 2016 May 28; 375(1):73-83. PubMed ID: 26944318
    [Abstract] [Full Text] [Related]

  • 33. IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway.
    Zheng Q, Diao S, Wang Q, Zhu C, Sun X, Yin B, Zhang X, Meng X, Wang B.
    J Cell Mol Med; 2019 Jan 28; 23(1):357-369. PubMed ID: 30353649
    [Abstract] [Full Text] [Related]

  • 34. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells via PI3K/Akt Pathway.
    Su RY, Hsueh SC, Chen CY, Hsu MJ, Lu HF, Peng SF, Chen PY, Lien JC, Chen YL, Chueh FS, Chung JG, Yeh MY, Huang YP.
    Anticancer Res; 2021 Apr 28; 41(4):1859-1870. PubMed ID: 33813391
    [Abstract] [Full Text] [Related]

  • 35. Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma.
    Mikheev AM, Mikheeva SA, Severs LJ, Funk CC, Huang L, McFaline-Figueroa JL, Schwensen J, Trapnell C, Price ND, Wong S, Rostomily RC.
    Mol Oncol; 2018 Jun 28; 12(7):1188-1202. PubMed ID: 29754406
    [Abstract] [Full Text] [Related]

  • 36. MYC-mediated upregulation of PNO1 promotes glioma tumorigenesis by activating THBS1/FAK/Akt signaling.
    Chen X, Guo ZQ, Cao D, Chen Y, Chen J.
    Cell Death Dis; 2021 Mar 04; 12(3):244. PubMed ID: 33664245
    [Abstract] [Full Text] [Related]

  • 37. PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling.
    Thomas SL, Alam R, Lemke N, Schultz LR, Gutiérrez JA, Rempel SA.
    Neuro Oncol; 2010 Sep 04; 12(9):941-55. PubMed ID: 20472716
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK, Kim HS, Jin T, Hwang EH, Jung M, Moon WK.
    BMC Cancer; 2016 Aug 02; 16():570. PubMed ID: 27484639
    [Abstract] [Full Text] [Related]

  • 39. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
    Xiao Q, Dong M, Cheng F, Mao F, Zong W, Wu K, Wang H, Xie R, Wang B, Lei T, Guo D.
    Int J Oncol; 2018 Sep 02; 53(3):1069-1082. PubMed ID: 30015847
    [Abstract] [Full Text] [Related]

  • 40. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G, Sun Y, Hong R, Xiong J, Lu Y, Liu Y, Lu J, Zhang Z, Guo C, Nan Y, Huang Q.
    Clin Transl Oncol; 2020 Aug 02; 22(8):1252-1262. PubMed ID: 31865606
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.